Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Smith, JD
   Mouse models of atherosclerosis
   LABORATORY ANIMAL SCIENCE
   
   J.D. Smith, "Mouse models of atherosclerosis", LAB ANIM SC, 48(6), 1998, pp. 573-579
2. ZSIGMOND E; FUKE Y; LI L; KOBAYASHI K; CHAN L
   RESISTANCE OF CHYLOMICRON AND VLDL REMNANTS TO POSTHEPARIN LIPOLYSIS IN APOE-DEFICIENT MICE - THE ROLE OF APOE IN LIPOPROTEIN LIPASE-MEDIATED LIPOLYSIS IN-VIVO AND IN-VITRO
   Journal of lipid research
   
   E. Zsigmond et al., "RESISTANCE OF CHYLOMICRON AND VLDL REMNANTS TO POSTHEPARIN LIPOLYSIS IN APOE-DEFICIENT MICE - THE ROLE OF APOE IN LIPOPROTEIN LIPASE-MEDIATED LIPOLYSIS IN-VIVO AND IN-VITRO", Journal of lipid research, 39(9), 1998, pp. 1852-1861
3. HOFKER MH; VANVLIJMEN BJM; HAVEKES LM
   TRANSGENIC MOUSE MODELS TO STUDY THE ROLE OF APOE IN HYPERLIPIDEMIA AND ATHEROSCLEROSIS
   Atherosclerosis
   
   M.H. Hofker et al., "TRANSGENIC MOUSE MODELS TO STUDY THE ROLE OF APOE IN HYPERLIPIDEMIA AND ATHEROSCLEROSIS", Atherosclerosis, 137(1), 1998, pp. 1-11
4. CARMELIET P; MOONS L; COLLEN D
   MOUSE MODELS OF ANGIOGENESIS, ARTERIAL-STENOSIS, ATHEROSCLEROSIS AND HEMOSTASIS
   Cardiovascular Research
   
   P. Carmeliet et al., "MOUSE MODELS OF ANGIOGENESIS, ARTERIAL-STENOSIS, ATHEROSCLEROSIS AND HEMOSTASIS", Cardiovascular Research, 39(1), 1998, pp. 8-33
5. HENDRIKS WL; VANDERSMANDEBEER F; VANVLIJMEN BJM; VANVARK LC; HOFKER MH; HAVEKES LM
   UPTAKE BY J774 MACROPHAGES OF VERY-LOW-DENSITY LIPOPROTEINS ISOLATED FROM APOE-DEFICIENT MICE IS MEDIATED BY A DISTINCT RECEPTOR AND STIMULATED BY LIPOPROTEIN-LIPASE
   Arteriosclerosis, thrombosis, and vascular biology
   
   W.L. Hendriks et al., "UPTAKE BY J774 MACROPHAGES OF VERY-LOW-DENSITY LIPOPROTEINS ISOLATED FROM APOE-DEFICIENT MICE IS MEDIATED BY A DISTINCT RECEPTOR AND STIMULATED BY LIPOPROTEIN-LIPASE", Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 498-504
6. NOZAKI S; ITO Y; NAKAGAWA T; YAMASHITA S; SASAKI J; MATSUZAWA Y
   AUTOIMMUNE HYPERLIPIDEMIA WITH INHIBITORY MONOCLONAL-ANTIBODIES AGAINST LOW-DENSITY-LIPOPROTEIN BINDING TO FIBROBLASTS IN A CASE WITH MULTIPLE-MYELOMA
   Internal medicine
   
   S. Nozaki et al., "AUTOIMMUNE HYPERLIPIDEMIA WITH INHIBITORY MONOCLONAL-ANTIBODIES AGAINST LOW-DENSITY-LIPOPROTEIN BINDING TO FIBROBLASTS IN A CASE WITH MULTIPLE-MYELOMA", Internal medicine, 36(12), 1997, pp. 920-925
7. TSUKAMOTO K; SMITH P; GLICK JM; RADER DJ
   LIVER-DIRECTED GENE-TRANSFER AND PROLONGED EXPRESSION OF 3 MAJOR HUMAN APOE ISOFORMS IN APOE-DEFICIENT MICE
   The Journal of clinical investigation
   
   K. Tsukamoto et al., "LIVER-DIRECTED GENE-TRANSFER AND PROLONGED EXPRESSION OF 3 MAJOR HUMAN APOE ISOFORMS IN APOE-DEFICIENT MICE", The Journal of clinical investigation, 100(1), 1997, pp. 107-114
8. FAZIO S; LINTON MF
   MURINE BONE-MARROW TRANSPLANTATION AS A NOVEL-APPROACH TO STUDYING THE ROLE OF MACROPHAGES IN LIPOPROTEIN METABOLISM AND ATHEROGENESIS
   Trends in cardiovascular medicine
   
   S. Fazio e M.F. Linton, "MURINE BONE-MARROW TRANSPLANTATION AS A NOVEL-APPROACH TO STUDYING THE ROLE OF MACROPHAGES IN LIPOPROTEIN METABOLISM AND ATHEROGENESIS", Trends in cardiovascular medicine, 6(2), 1996, pp. 58-65
9. MALOSKY S; KOLANSKY DM
   GENE-THERAPY FOR ISCHEMIC-HEART-DISEASE
   Current opinion in cardiology
   
   S. Malosky e D.M. Kolansky, "GENE-THERAPY FOR ISCHEMIC-HEART-DISEASE", Current opinion in cardiology, 11(4), 1996, pp. 361-368
10. GOLDBERG IJ
    LIPOPROTEIN-LIPASE AND LIPOLYSIS - CENTRAL ROLES IN LIPOPROTEIN METABOLISM AND ATHEROGENESIS
    Journal of lipid research
    
    I.J. Goldberg, "LIPOPROTEIN-LIPASE AND LIPOLYSIS - CENTRAL ROLES IN LIPOPROTEIN METABOLISM AND ATHEROGENESIS", Journal of lipid research, 37(4), 1996, pp. 693-707
11. FEUSSNER G
    SEVERE XANTHOMATOSIS ASSOCIATED WITH FAMILIAL APOLIPOPROTEIN-E DEFICIENCY
    Journal of Clinical Pathology
    
    G. Feussner, "SEVERE XANTHOMATOSIS ASSOCIATED WITH FAMILIAL APOLIPOPROTEIN-E DEFICIENCY", Journal of Clinical Pathology, 49(12), 1996, pp. 985-989
12. TERAMOTO T; KINOSHITA M; KAWAMURA M; LIANG YQ; KANEKO K; SHIMAZU N; SUGA S; AKATUKA N; YAMANAKA M
    CHARACTERIZATION OF LOW-DENSITY-LIPOPROTEIN IN APOLIPOPROTEIN-E DEFICIENCY IN A PATIENT WITHOUT CORONARY ATHEROSCLEROSIS
    Clinica chimica acta
    
    T. Teramoto et al., "CHARACTERIZATION OF LOW-DENSITY-LIPOPROTEIN IN APOLIPOPROTEIN-E DEFICIENCY IN A PATIENT WITHOUT CORONARY ATHEROSCLEROSIS", Clinica chimica acta, 247(1-2), 1996, pp. 159-166
13. SMITHIES O; MAEDA N
    GENE TARGETING APPROACHES TO COMPLEX GENETIC-DISEASES - ATHEROSCLEROSIS AND ESSENTIAL-HYPERTENSION
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    O. Smithies e N. Maeda, "GENE TARGETING APPROACHES TO COMPLEX GENETIC-DISEASES - ATHEROSCLEROSIS AND ESSENTIAL-HYPERTENSION", Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5266-5272
14. GRANOT E; SCHWIEGELSHOHN B; TABAS I; GORECKI M; VOGEL T; CARPENTIER YA; DECKELBAUM RJ
    EFFECTS OF PARTICLE-SIZE ON CELL UPTAKE OF MODEL TRIGLYCERIDE-RICH PARTICLES WITH AND WITHOUT APOPROTEIN-E
    Biochemistry
    
    E. Granot et al., "EFFECTS OF PARTICLE-SIZE ON CELL UPTAKE OF MODEL TRIGLYCERIDE-RICH PARTICLES WITH AND WITHOUT APOPROTEIN-E", Biochemistry, 33(50), 1994, pp. 15190-15197
15. ROSENFELD ME; BUTLER S; ORD VA; LIPTON BA; DYER CA; CURTISS LK; PALINSKI W; WITZTUM JL
    ABUNDANT EXPRESSION OF APOPROTEIN-E BY MACROPHAGES IN HUMAN AND RABBIT ATHEROSCLEROTIC LESIONS
    Arteriosclerosis and thrombosis
    
    M.E. Rosenfeld et al., "ABUNDANT EXPRESSION OF APOPROTEIN-E BY MACROPHAGES IN HUMAN AND RABBIT ATHEROSCLEROTIC LESIONS", Arteriosclerosis and thrombosis, 13(9), 1993, pp. 1382-1389